ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
長春高新技術產業(集團)股份有限公司(臨時代碼)
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
- -
香港流通股本:
- -
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
市銷率:
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
長春高新(000661.SZ):GenSci142膠囊境內生產藥品註冊臨牀試驗申請獲批准
智通财经
·
11/27
「東北藥茅」長春高新擬赴港上市 證監會就募資用途等問題要求補充説明
红星资本局
·
11/17
新股消息 | 長春高新(000661.SZ)擬港股上市 中國證監會要求補充説明募集資金用途等
智通财经
·
11/14
長春高新:港交所審批後續需獲證監會備案並通過聯交所聆訊
新浪财经
·
11/06
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/91272"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"91272","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91272\",,,,,undefined,":{"symbol":"91272","market":"HK","secType":"STK","nameCN":"長春高新技術產業(集團)股份有限公司(臨時代碼)","latestPrice":0,"timestamp":1764921600000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":0,"latestTime":"12-05 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0,"lotSize":0,"spreadScale":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91272\",,,,,undefined,":{"symbol":"91272","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/91272\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"91272\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"91272\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"91272\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586546243","title":"長春高新(000661.SZ):GenSci142膠囊境內生產藥品註冊臨牀試驗申請獲批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2586546243","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586546243?lang=zh_tw&edition=fundamental","pubTime":"2025-11-27 16:55","pubTimestamp":1764233713,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长春高新(000661.SZ)公告,公司子公司长春金赛药业有限责任公司(简称“金赛药业”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,金赛药业GenSci142胶囊注册临床试验申请获得批准。据悉,GenSci142胶囊是金赛药业开发的一款1类创新生物制品,拟用于细菌性阴道病的治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0075","BK0046","91272","BK0188","BK0239","BK0028","000661","BK0057"],"gpt_icon":0},{"id":"2584606794","title":"「東北藥茅」長春高新擬赴港上市 證監會就募資用途等問題要求補充説明","url":"https://stock-news.laohu8.com/highlight/detail?id=2584606794","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584606794?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 22:35","pubTimestamp":1763390100,"startTime":"0","endTime":"0","summary":" 11月17日消息,在9月底递表港交所后,“生长激素一哥”长春高新 近日收到证监会境外发行上市备案补充材料要求。 11月14日,证监会共对10家拟港股上市企业出具补充材料要求。其中,证监会就长春高新募集资金用途、下属子公司开展相关业务及具体运营情况等问题要求长春高新进行补充说明。然而,也因为过度依赖生长激素业务,且公司带状疱疹疫苗遭遇挫折,2024年及2025年上半年,长春高新营收、净利润双双出现下滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-17/doc-infxtqvw4711065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0188","91272","BK0046","000661","BK0057","BK0028","BK0075"],"gpt_icon":0},{"id":"2583508022","title":"新股消息 | 長春高新(000661.SZ)擬港股上市 中國證監會要求補充説明募集資金用途等","url":"https://stock-news.laohu8.com/highlight/detail?id=2583508022","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583508022?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 19:48","pubTimestamp":1763120916,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月14日,中国证监会公布《境外发行上市备案补充材料要求》。中国证监会国际司公示10家企业补充材料要求,其中,公示提到要求长春高新补充说明公司募集资金用途、以及业务涉及AI大模型的具体情况等。据港交所9月29日披露,长春高新技术产业(集团)股份有限公司向港交所主板提交上市申请书,中信建投国际为其独家保荐人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0075","91272","BK0188","BK0057","BK0046","000661","BK0239"],"gpt_icon":0},{"id":"2581662068","title":"長春高新:港交所審批後續需獲證監會備案並通過聯交所聆訊","url":"https://stock-news.laohu8.com/highlight/detail?id=2581662068","media":"新浪财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581662068?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 17:00","pubTimestamp":1762419600,"startTime":"0","endTime":"0","summary":"投资者提问:谢谢回复!请问港交所的审批流程是怎样的?能具体介绍一下吗?谢谢!董秘回答(长春高新SZ000661):您好,对于公司来说,后续需要取得中国证监会的备案并需通过联交所聆讯,谢谢!查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106172631a6e58e29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106172631a6e58e29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HKXCY","LU0197773673.USD","LU0516422440.USD","LU0594300419.USD","LU1242518857.USD","LU0821914370.USD","LU1051768304.USD","LU0651947912.USD","LU0197773160.USD","LU0348825331.USD","LU1282649141.HKD","LU1051769294.HKD","LU1048596156.SGD","LU0084288322.USD","LU1226287529.USD","LU1282648689.USD","LU1981816686.USD","LU1515016050.SGD","80388","LU0320764599.SGD","LU0456846285.SGD","LU1211504680.USD","LU1734074674.USD","HEXmain","SG9999001051.SGD","LU0651946864.USD","LU1993786604.SGD","LU0797268264.HKD","LU1807302812.USD","LU0417516902.SGD","IE00B3T34201.USD","LU1023057109.AUD","LU0359202008.SGD","LU1481107354.HKD","LU1366334651.USD","LU0918141705.HKD","LU0417516738.SGD","LU0819123356.HKD","LU1642822792.SGD","LU0370786039.SGD","LU0918141887.USD","LU0708995583.HKD","91272","LU0819121731.USD","LU0516423091.SGD","LU0261947096.USD","BK1610","00388","LU0048597586.USD","LU0106959298.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/91272\",params:#limit:6,delay:false,,,undefined,":[]}}